Episodes

  • Healthcare Marketing Strategies for Reaching Diverse Audiences
    May 14 2024
    Amanda Powers-Han, Chief Marketing Officer, Greater Than One, and Pharmaceutical Executive Editorial Advisory Board member, discusses how improved DE&I in healthcare marketing strategies not only reach diverse audiences more effectively but also contribute to improved patient care outcomes, challenges faced in crafting culturally sensitive messages, and much more.

    Link to Honeycomb Health video: https://www.pharmexec.com/view/going-beyond-visuals-to-connect-with-diverse-audiences
    Show more Show less
    13 mins
  • A Decade in the Anti-Obesity Arena
    Apr 30 2024
    Currax Pharmaceuticals CEO, George Hampton discusses what patient success has looked like for their oral anti-obesity medication, how expanded access can help with the world's obesity epidemic, when prices should come down, and much more.
    Show more Show less
    23 mins
  • Fierce Females in the Life Science Space
    Mar 28 2024
    In this week’s episode, in recognition of international women’s month, Editor Miranda Schmalfuhs has compiled audio clips from interviews with female KOLs that she's been fortunate enough to speak with over this past month for content across a few of our brands.

    Featured in this episode are:
    Emma Banks, CEO, ramarketing
    Jill Jaroch, Senior Director, Women’s Health & Urology Marketing, Astellas
    Marie Teil, Global Head, UCB’s Women of Childbearing Age Program
    Julia Lakeland, Chief Product Office, uMotif

    If you enjoyed this episode of our podcast, we encourage you to seek out the longer version of each of these videos—Linked on our website!

    Show more Show less
    16 mins
  • Gen-Z Influence on Pharma M&A
    Mar 14 2024
    Ian Baer, Founder and Chief Soothsayer, Sooth, discusses their recent data and research about some massive behavioral shifts occurring across Gen-Z, and how pharmaceutical companies and healthcare advertising agencies can adapt their strategies to attract the ever elusive generation.
    Show more Show less
    21 mins
  • Recent Licensing Agreement Poised to Advance Company ADC
    Jan 26 2024
    Jingsong Wang, Chairman of Nona Biosciences, discusses Nona Biosciences’ recent exclusive license agreement with Pfizer Inc. for the development and commercialization of HBM9033, an innovative antibody-drug conjugate (ADC) targeting MSLN, a key antigen in various solid tumors. Wang believes that the partnership will significantly advance Nona's Harbour Mice® platform and ADC ecosystem.
    Show more Show less
    23 mins
  • Cell and Gene Therapy Check-in 2024
    Jan 18 2024
    Fran Gregory, VP of Emerging Therapies, Cardinal Health discusses her career, how both CAR-T therapies and personalization have been gaining momentum and what kind of progress we expect to see from them, some of the biggest hurdles facing their section of the industry, the importance of patient advocacy and so much more. 
    Show more Show less
    33 mins
  • Reshaping Pharmacovigilance in the age of AI
    Jan 4 2024
    Sameer Lal, Sr. Vice President, Enterprise Medical Solutions at Indegene, discusses findings from their new study about Reshaping Pharmacovigilance in the age of AI, digital/generative AI opportunities, how quickly the industry is adopting this technology, and much more.
    Show more Show less
    17 mins
  • Patient Centric Diabetes Care
    Dec 14 2023
    Dr. Julien Boisdron, Global Head of OneMedical / Chief Medical Officer Roche Diabetes Care, discusses the current standard for diabetes care, the importance of patient advocacy and mental health, what the future of this space holds, and much more. 
    Show more Show less
    15 mins